University of Jordan
Amman, Jordan
NCT Number: NCT06610292
This study aims to assess the effects of Pharmacist-led medication reconciliation on hospitalized elderly patients aged above 65 at a leading tertiary military hospital in Jordan.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Amman, Jordan
A four-month randomized controlled trial was conducted at King Hussein Medical Hospital (KHMH), one of the Royal Military Medical Services (RMS) tertiary hospitals located in central Amman. During the study period, 128 patients were selected using convenience sampling. Later, medication histories were compared between pre-admission and admission records to obtain the Best Possible Medication History (BPMH) and identify medication discrepancies, which were categorized as either intentional (documentation errors) or unintentional discrepancies.
The already selected patients were randomly allocated into two groups (intervention and control groups). Then, Pharmacist-led medication reconciliation services were provided to the intervention group and standard care was provided to the control group. Also at discharge the number of medication discrepancies was documented. Linear regression analysis was performed to assess risk factors associated with the occurrence of unintentional discrepancies.
Within 30 days post-discharge, patients were assessed for any hospital re-admissions, emergency department visits and medication-related side effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Upon admission, information about patients Best Possible Medication History (BPMH) was extracted. Information on current medications, both regular and as-needed, was also recorded. All data were cross-referenced with the electronic records and verified through patients or caregivers interviews to create a comprehensive medication list.
Then, comparison was conducted between standard care medication list and Pharmacist-led medication reconciliation list to identify any possible medication discrepancies. Also, during hospital stay and upon discharge emerging medication discrepancies were assessed and resolved.
Moreover, the impacts on healthcare resources utilization within 30 days post-discharge was measured. This includes evaluating hospital re-admissions, emergency department visits, and the occurrence of any adverse drug events (ADEs).
Time frame: Up to 20 weeks
Linear regression analysis was performed to assess risk factors associated with the occurrence of medication discrepancies in elderly patients.
Time frame: Up to 16 weeks
Number of resolved medication discrepancies was documented upon discharge after providing pharmacist-led medication reconciliation services.
Time frame: Up to 20 weeks
Elderly patients were assessed for number of hospital re-admissions within 30 days of discharge at control and intervention groups.
Time frame: Up to 20 weeks
Elderly patients were assessed for number of emergency department visits within 30 days of discharge at control and intervention groups.
Time frame: Up to 20 weeks
Elderly patients were assessed for incidence of medications side effects within 30 days of discharge at control and intervention groups.
University of Jordan
Other
Effects of Pharmacist-led Medication Reconciliation Services on Geriatric Patients At a Leading Military Hospital in Jordan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07577349
Clinical Deterioration, Disease Attributes
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07383519
Combination Therapy, Geriatric Patients
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07311447
Agnosia, Cognition Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07203924
Acute Coronary Syndrome, Acute Coronary Syndromes
Balıkesir, Turkey (Türkiye)
View Trial Details